Sign up to receive our news roundups

NTDs at the Disability Summit, Xenomonitoring Found to Be Useful in Monitoring Re-Emergence of Lymphatic Filariasis & Other NTD News

News roundup

This news roundup is a collection of headlines and other items on neglected tropical diseases, and does not reflect the work or the views of the Neglected Tropical Diseases Support Center.

Xenomonitoring

A gravid trap collection bag is inspected by an entomologist during the xenomonitoring study in Bangladesh.

SETH R. IRISH ET AL./EUREKALERT!

Lymphatic filariasis

Mosquito screening useful in monitoring lymphatic filariasis re-emergence

Avren Keating
EurekAlert!
To ensure elimination of the Wuchereria bancrofti, a parasitic roundworm that causes lymphatic filariasis (LF), public health workers must follow up mass drug administration with careful monitoring for recurrence. To that end, a study published this week in PLOS Neglected Tropical Diseases analyzes the effectiveness of mosquito screening as a tool to gauge parasite presence. "The practical application of xenomonitoring activities is worthy of discussion," the researchers say. "Further operational research and information sharing about how to programmatically simplify and standardize [molecular xenomonitoring, or] MX evaluations will also make these evaluations more accessible to a larger number of LF endemic countries entering the post-elimination validation period."

Molecular xenomonitoring for Wuchereria bancrofti in Culex quinquefasciatus in two districts in Bangladesh

Seth R. Irish et al.
PLOS Neglected Tropical Diseases
Careful monitoring for recrudescence of Wuchereria bancrofti infection is necessary in communities where mass drug administration (MDA) for the elimination of lymphatic filariasis (LF) as a public health problem has been stopped. . . Molecular xenomonitoring (MX), a method by which parasite infection in the mosquito population is monitored, has also been proposed as a sensitive method to determine whether the parasite is still present in the human population. The aim of this study was to conduct an MX evaluation in two areas of Bangladesh, one previously endemic district that had stopped MDA (Panchagarh), and part of a non-endemic district (Gaibandha) that borders the district where transmission was most recently recorded.

Effects of cross-mating on susceptibility of synonymous mosquitoes, Anopheles paraliae and Anopheles lesteri

Watcharatip Dedkhad et al.
Acta Tropica
In Southeast Asia, Anopheles lesteri (recently synonymized with An. paraliae) is a competent vector for Plasmodium parasites, but its ability to transmit parasites that cause lymphatic filariasis has yet to be determined. In this study, the susceptibility of An. lesteri and An. paraliae to Brugia malayi parasites was determined by comparing with the control mosquito, Aedes togoi. We found that the infection prevalence per infected mosquito in An. paraliae was significantly lower than that in Ae. togoi in all experiments.

Onchocerciasis

Onchocerciasis: the last challenge

Pan American Health Organization
Onchocerciasis or “river blindness” is a parasitic disease that affects the skin and eyes and, if left untreated, can cause blindness. The territory inhabited by the Yanomami indigenous community in Latin America is the disease’s final frontier. . . “We are currently in the pre-elimination stage,” said Joao Batista, Brazilian Program Manager for the Elimination of Onchocerciasis. “Results of parasitological and entomological examinations reveal a very low level of permanence of the infection, “ he added.

Pioneering Community-Based Ivermectin Distribution in Cameroon

Victoria Sheffield
The International Agency for the Prevention of Blindness
Working closely with Cameroon’s National Onchocerciasis Control Programme, the African Programme for Onchocerciasis Control (APOC), and the Lions SightFirst Programme, over 1.1 million people were treated with Mectizan in 2017. This represents 100% coverage of those eligible and 100% geographic coverage reflecting a steady increase to a cumulative total of 12.8 million people treated. Over 7,000 Community Directed Distributors (CDDs) in 3,522 communities are trained annually.

Schistosomiasis

Schistosomiasis outbreak in Myanmar

Robert Herriman
Outbreak News Today
On Saturday, Union Minister Dr Myint Htwe announced the number of schistosomiasis cases has risen into the hundreds during a meeting on the topic, according to a Ministry of Health and Sports news release. The first cases of schistosomiasis in the country were discovered in March 2018, with about 59 cases in Sittwe Town of Rakhine State. Now officials say that more than 500 cases have been seen Inle, Shan State and Rakhine.

Why male menstruation was an expected occurrence in Egypt in the 1900s

Mildred Europa Taylor
Face 2 Face Africa
Until recent times, blood in urine, which is a common sign that schistosomiasis, a chronic disease caused by parasites, has taken place, was seen as something else by some folks in Egypt. Especially among the uneducated, they believed it was a form of menstruation, according to accounts. Schistosomiasis, also known as Bilharzia, has been described informally as the leading cause of menstruation in boys.

Nigeria beat the beast of Ebola: Now for some other worthy foes

Mark Doyle
Daily Trust (Nigeria)
What would you think if you learnt that over 16 million Nigerian children had a disease that can cause internal bleeding and social stigma - but that only a little over half of them were getting treatment? You’d be outraged, of course, and expect the kids to be looked after. But what would you then think if you knew that the cost of solving this problem was drugs that cost less than 200 Naira per person per year? You would probably wonder why the treatment was not given to everyone as soon as possible. The disease in question is waterborne Bilharzia, or, to give its scientific name, Schistosomiasis.

Soil-Transmitted Helminthiasis

Relationships between the weaning period and the introduction of complementary foods in transmission of gastrointestinal . . .

James R Palmieri et al.
Research and Reports in Tropical Medicine
This study was to investigate weaning practices used by mothers when transitioning infants from breast milk to complementary foods and to determine the role these foods have in the transmission of gastrointestinal parasites. Forty percent of mothers involved in this survey reported that their children were diagnosed and/or treated for gastrointestinal parasitic infection. Routes of infection of protozoan and helminth parasites likely resulted from contaminated complementary foods and water given to infants while still breast-feeding or from contaminated foods after breast-feeding had been completed.

Prevalence of soil-transmitted helminths and Schistosoma mansoni among a population-based sample of children in Amhara, Ethiopia

Andrew W. Nute et al.
Parasites & Vectors
From 2011 to 2015, seven trachoma impact surveys in 150 districts across Amhara, Ethiopia, included in their design a nested study to estimate the zonal prevalence of intestinal parasite infections including soil-transmitted helminths (STH) and Schistosoma mansoni. These surveys determined that from 2011 to 2015, STH and Schistosoma mansoni were present throughout the region, and accordingly, these results were used to guide PC distribution to school-age children in Amhara.

The effect of cumulative soil-transmitted helminth infections over time on child development

Brittany Blouin et al.
International Journal of Epidemiology
Limited research has documented an association between soil-transmitted helminth (STH) infections and child development. This has recently been identified as an important knowledge gap. A longitudinal cohort study was conducted in Iquitos, Peru, between September 2011 and July 2016. A cohort of 880 children, recruited at 1 year of age, was followed up to 5 years. STH infection was measured annually and child development was measured with the Wechsler Preschool and Primary Scale of Intelligence III (WPPSI-III) at 5 years. These results document an association between STH infection and child development.

Complex interactions in soil-transmitted helminth co-infections from a cross-sectional study in Sri Lanka

Hannah C Lepper et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
Co-infection with multiple soil-transmitted helminth (STH) species is common in communities with a high STH prevalence. The life histories of STH species share important characteristics, particularly in the gut, and there is the potential for interaction, but evidence on whether interactions may be facilitating or antagonistic are limited. We suggest that between-species interactions that differ by species could explain these results, but further research in different populations is needed to support this theory.

Trachoma

Global Disability Summit: Leaving no one behind

The Queen Elizabeth Diamond Jubilee Trust
Today, the UK government is hosting its first Global Disability Summit with the International Disability Alliance and the government of Kenya to galvanize global efforts to address disability inclusion in international development and humanitarian assistance. To coincide with this important meeting, we’re shining a light on how the Trust’s Trachoma Initiative is leaving no one behind by reaching some of the world’s most remote and marginalized people, to stamp out the world’s leading infectious cause of blindness.

Quality Assurance and Quality Control in the Global Trachoma Mapping Project

Anthony Solomon et al.
The American Journal of Tropical Medicine and Hygiene
In collaboration with the health ministries that we serve and other partners, we set out to complete the multiple-country Global Trachoma Mapping Project. To maximize the accuracy and reliability of its outputs, we needed in-built, practical mechanisms for quality assurance and quality control. This article describes how those mechanisms were created and deployed.

Shedding Light on NTDs: Trachoma

Lauren Goodwin
The Disease Daily
Welcome back to “Shedding Light on NTDs”. This week, we will be discussing the leading infectious cause of preventable blindness, a neglected tropical disease known as trachoma. It is a disease caused by the bacterium Chlamydia trachomatis and affects approximately 110 million people worldwide.

An eye for azithromycin: review of the literature

Kostas A. Kagkelaris, Olga E. Makri, Constantine D. Georgakopoulos and George D. Panayiotakopoulos
Therapeutic Advances in Opthalmology
Azithromycin is used widely in clinical practice and recently it is available in topical solution for ophthalmic use. The purpose of the current publication is to summarize the newest information on azithromycin’s clinical usefulness over ocular diseases.

Cross-cutting

NTDs remain a leading cause of disabilities. Are we doing enough?

Liverpool School of Tropical Medicine
Disabilities stemming from Neglected Tropical Diseases (NTDs) are substantial. A 2017 departmental plan dataset (link is external) published by DFID reported that, out of the total people reached by DFID-supported NTD interventions, 98% received preventative chemotherapy but only 0.1% received morbidity management. This goes to show that more work needs to be done for disability alleviation.

Neglected Tropical Diseases and Disability - What is the Link?

Hannah Kuper
COR-NTD Blog
In this post, Professor Hannah Kuper, Director of the International Centre for Evidence in Disability, London School of Hygiene & Tropical Medicine assesses the relationship between neglected tropical diseases and disability and asks how best these two commitments can be met.

How a Simple Finance Mechanism is Building Country Ownership of Global Health Efforts

Amy Doherty
RTI International
We use fixed obligation grants (FOGs) as a primary mechanism to fund country program implementation. These fixed-price instruments provide a set amount of funding for the achievement of a pre-determined number of activities or milestones. . . . To date, RTI and partners have administered more than 1,600 FOGs to host government entities through USAID’s ENVISION Project. As a result, more than 1.1 billion treatments have been provided in communities at risk for [neglected tropical diseases, or] NTDs, led by the governments themselves, with support from ENVISION.

Notice of Award: Control and Elimination Program for Neglected Tropical Diseases, Element One

USAID
USAID’s Bureau for Global Health, Office of Infectious Disease, Neglected Tropical Diseases Division is pleased to announce the award of the Control and Elimination Program for Neglected Tropical Diseases (CEP-NTD) Element One. . . This cooperative agreement has been awarded to FHI 360 with a $200 million ceiling. FHI 360 has arranged a consortium of partners to implement the objectives of CEP-NTD: Helen Keller International, Health Development International, Deloitte, World Vision, Americares and the AIM Initiative. This cooperative agreement will support Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone and Togo. The CEP-NTD Element Two award, which includes a different subset of focal countries, is still under solicitation.

UHC and NTDs: monitoring equity with essential services for marginalized communities

Ashok Moloo
World Health Organization
The World Health Organization (WHO) recently developed an index to measure coverage of services for the control, prevention and elimination of neglected tropical diseases (NTDs). The index largely involves the five high burden diseases for which WHO uses large-scale treatment (preventive chemotherapy) to reach hundreds of millions of people who are simultaneously affected by more than one NTD. But a broader index, including services for other diseases, could also be developed at regional and country levels.

Monitoring equity in universal health coverage with essential services for neglected tropical diseases

Christopher Fitzpatrick et al.
The Lancet Global Health
A service coverage index has recently been proposed to monitor progress towards universal health coverage (UHC), and baseline results for 2015 are available. However, evidence on equity in that progress is scarce. The service coverage index did not consider services for neglected tropical diseases (NTDs), a group of preventable diseases defined by WHO member states on the basis of the disproportionate burden they place on their poorest, remotest, and otherwise most marginalised communities. Because of the much-needed equity lens that it could provide, NTD service coverage should not be neglected in efforts to monitor UHC progress.

[COMMENT] Preventive chemotherapy coverage for neglected tropical diseases: does one metric fit all?

Elizabeth A Cromwell and Nancy Fullman
The Lancet Global Health
In The Lancet Global Health, Christopher Fitzpatrick and colleagues developed an [neglected tropical disease, or] NTD service coverage index based on preventive chemotherapy for trachoma, lymphatic filariasis, onchocerciasis, soil-transmitted helminths, and schistosomiasis, proposing the first-ever aggregate NTD program performance metric for MDA. . . Ideally, NTD program progress would be measured by broader interventions received (ie, vector control, hygiene promotion, and water and sanitation improvements) and case management; however, data are not consistently available for all of these key interventions and services. Ultimately, people in the bottom billion only stand to gain if preventive chemotherapy coverage metrics can be translated into improved NTD control and elimination worldwide. A key step towards this aim is strengthened monitoring of who receives preventive chemotherapy and where the largest gaps remain.

iChord – A New Approach to Community Engagement in Global Health

Molly Starke
COR-NTD Blog
The “final mile” of an [mass drug administration, or] MDA relies on the hard work of community volunteers and specifically, community drug distributors (CDDs). The importance of these volunteers cannot be overstated. They bridge the gap between the NTD programs and the communities they are serving, often times leading by example by taking medicines alongside the communities and ensuring the cultural acceptability of the MDA. . . Sustaining the motivation of these volunteers is critical – but how? This question is at the heart of iChord, the new collaboration between the Bruyère Research Institute (Canada), the African Institute for Health and Development (AIHD) (Kenya), University of Health and Allied Sciences (UHAS) (Ghana), and the Ministries of Health in Côte d’Ivoire and Uganda.

Other

A potential treatment for visceral leishmaniasis

Roddy Isles
University of Dundee
A new preclinical candidate drug with the potential to treat visceral leishmaniasis, one of the world’s major neglected diseases, has been discovered through a close collaboration between the University of Dundee, GSK and Wellcome. . . Diana Tay, from Wellcome’s Innovation team, said, “This potential treatment is in pre-clinical stages of research, but could be used to treat those with the most severe form of leishmaniasis, which, untreated, kills 95% of people affected.

Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

Susan Wyllie, Michael Thomas and Ian H. Gilbert
Nature
Visceral leishmaniasis causes considerable mortality and morbidity in many parts of the world. There is an urgent need for the development of new, effective treatments for this disease. Here we describe the development of an anti-leishmanial drug-like chemical series based on a pyrazolopyrimidine scaffold.

Incidence of Endemic Human Cutaneous Leishmaniasis in the United States

Bridget E. McIlwee, Stephen E. Weiss and Gregory A. Hosler
JAMA Dermatology
Leishmaniasis is recognized as an endemic human disease in Africa, the Middle East, Asia, and South America. Yet despite case reports of endemic human leishmaniasis in the United States, and well-documented occurrences of disease in various animal vectors and reservoirs, the endemicity of leishmaniasis in North America has not yet been established.

Cystic echinococcosis in Peru: workshop and funding opportunities

Victor Del Rio Vilas and César Gavidia Chucán
The International Society for Neglected Tropical Diseases
Ahead of a ground-breaking cystic echinococcosis workshop in Lima on 16-19 October 2018, the ISNTD speaks to Dr. César Gavidia Chucán (Faculty of Veterinary Medicine at the Universidad Nacional Mayor de San Marcos, Peru) and Dr. Victor Del Rio Vilas (Lecturer in Infectious Disease Epidemiology at the University of Surrey) about current research gaps in CE and how the upcoming workshop will accelerate both the advocacy as well as the research agenda to tackle this disease.

US FDA Advisory Committee endorses effectiveness & safety of single-dose tafenoquine for the radical cure of P. vivax malaria

GlaxoSmithKline
GSK and Medicines for Malaria Venture (MMV) today announced that the Antimicrobial Drugs Advisory Committee (AMDAC) of the United States Food and Drug Administration (FDA) voted that there is substantial evidence of the effectiveness and adequate evidence of the safety of single-dose tafenoquine for the radical cure of Plasmodium vivax (P. vivax) malaria in patients 16 years of age and older.

Malaria’s ticking time bomb

Amy Maxmen
Nature
After years in decline, malaria infection rates seem to be on the rise in northeastern Cambodia, where people are moving deeper into lush, mosquito-ridden territories in search of timber and seasonal goods such as samrong (Scaphium affine). Their movements provide opportunities for P. falciparum — which requires both human and insect hosts — to thrive. . . As long as P. falciparum exists, it can resurge. And the last parasites remaining are the hardest to find. They reside in the hinterlands, borderlands and war zones — and in people who show no signs of the disease. “Malaria is very clever — it hides out where you don’t know and comes back when you aren’t ready,” says Ladda Kajeechiwa, a malaria-programme manager at a branch of the Mahidol Oxford Tropical Medicine Research Unit (MORU) in Mae Sot, Thailand.

Zika’s power, destructive in fetuses, might be turned against tumors, scientists say

Helen Branswell
STAT
As the world discovered in 2016, the seemingly benign Zika virus is capable of inflicting life-altering damage when it finds its way into the developing brains of fetuses. Now scientists hope to harness that horrible potential as a weapon to fight cancer. Several research groups are exploring whether Zika viruses could be unleashed on cancers, effectively wiping out the dangerous cells of a brain or central nervous system cancer. One group, at Nemours Children’s Hospital in Orlando, published findings of early-stage work Wednesday in the journal PLOS One.

First case of confirmed congenital Zika syndrome in continental Africa

Madalena Sassetti et al.
Transactions of the Royal Society of Tropical Medicine & Hygiene
Zika virus has been responsible for recent outbreaks in the western hemisphere with known neurological complications such as microcephaly. This complication has not been previously documented in continental Africa. We report on a newborn, born in Portugal, with microcephaly with confirmed congenital Zika virus infection (Asian lineage) imported from Angola with typical clinical and imaging findings. To our knowledge this is the first report that shows the circulation of the Asian lineage in Angola and the first report of a congenital Zika syndrome in continental Africa.

Upcoming Events 

Integrating and Scaline Mobile Community Health Data Systems: Experience from India, Ethiopia and Madagascar
August 1,  Webinar
Community health workers (CHWs) improve access to quality health services at the community level. Despite the critical role that CHWs play, governments often have limited insight into their activities, the quality of their services, the conditions of the communities that they serve, and how best to link these CHWs and their beneficiaries to the larger health system. To effectively monitor CHW services and improve public health management at the community level, practical, effective and integrated systems for data collection, analysis and monitoring are needed. Mobile technologies show great promise, but how do we ensure they are integrated with national HMIS systems and how do we scale them to meet the need? Highlighting case examples from three countries, this webinar presents the successes and challenges of linking a CHW workforce to larger national health systems with mobile technologies. Presenters will explore the technical process of integrating various mobile platforms; best practices and lessons learned building reports to facilitate data-based decision making at the government level; and how to design for scale within existing systems and considering the processes needed to integrate with those systems.

Tropical Medicine Cases and Neurocysticercosis Guidelines
August 8,  Webinar
What will be covered? A mix of interesting tropical medicine cases as well as one hour on the newly released IDSA and ASTMH co-authored neurocysticercosis guidelines, interspersed with relevant cases. Presenters: Leading tropical medicine experts Susan McLellan, MD, MPH, FIDSA, FASTMH, University of Texas Medical Branch, and Christina Coyle, MD, Albert Einstein College of Medicine, will lead the discussion. Dr. Coyle is a co-author of the neurocysticercosis guidelines.

Public Health Informatics Conference
August 20-23,  Atlanta, Georgia
Registration for the 2018 Public Health Informatics Conference is now open! Don’t miss this opportunity to connect with colleagues and address the science of public health informatics, evolving public health systems, and public health’s role in our nation’s expanding health information technology infrastructure.

5th International Conference on Neglected Tropical & Infectious Diseases
August 29-30,  Boston, Massachussetts
Theme: Uniting all to overcome and fight against NTD's & infectious diseases for improved health protection.

78th FIP World Congress of Pharmacy and Pharmaceutical Sciences
September 2-6, Glasgow, United Kingdom
The 2018 FIP congress in Glasgow, Scotland, invites pharmacy practitioners and pharmaceutical scientists from around the world to come together to consider ways of extending the role of pharmacists so that they play a full part in ensuring patients, and health systems, achieve full benefit from the medicines people take.

Gnatwork Bangladesh '18
September 2-6, Bangladesh
Our first international workshop will be held in Bangladesh on the 2 – 6 September 2018. We aim to bring together researchers who have an interest in blackflies, sandflies and biting midges for networking and sharing of expertise.The first day of our week-long workshop will consist of a conference day of talks, consisting of lectures from experts on vector ecology and epidemiology. We will also hold a short workshop on this day to discuss the current issues affecting vector research. Following this, we are holding a four-day training course for early-career researchers, to teach practical laboratory and field skills for research on sandflies, blackflies and biting midges.

Contol and Elimination of Visceral Leishmaniasis (Kala-azar)
September 3,  Online Course
The London School of Hygiene and Tropical Medicine is offering an online course bringing together all aspects of elimination and control together, this course provides a unique platform to learn about the tools needed for an effective VL control programme. The course contains examples from experts delivering current control and elimination programmes in South Asia and East Africa. The course provides learners unprecedented access to practical tools and insight into understanding the requirements and complexities of such programmes.

2018 ROP Africa Symposium
September 3-4,  Cape Town, South Africa
The International Paediatric Ophthalmology and Strabismus Council and The Department of Pediatric Ophthalmology at The Red Cross War Memorial Children’s Hospital, Cape Town are proud to announce the 2018 ROP Africa Symposium.

IAPB Council of Members Meeting
September 15-16,  Hyderabad, India
The 2018 International Agency for the Prevention of Blindness (IAPB) Council of Members will be held in Hyderabad and our local host will be L.V. Prasad Eye Institute who are celebrating the 20th anniversary of ICARE (International Centre for Advancement of Rural Eye Care). We are expecting 400 delegates between the 15-16 September to celebrate the progress that has been made in India and across the South East Asia Region as well as looking ahead at the challenges that eye health faces not just in the region but across the globe.

RSTMH Annual Meeting 2018
September 19-20,  London, UK
The theme of [The Royal Society for Tropical Medicine and Hygiene, or] RSTMH’s 2018 two-day Annual Meeting is intersections of neglected tropical diseases (NTDs) with non-communicable diseases (NCDs) and the Sustainable Development Goals. We will bring together voices from different sectors, locations and disease areas to showcase the lesser-known problems caused by intersections, and their impact.

First International Podoconiosis Conference
September 23, Addis Ababa, Ethiopia
The theme for this is ‘Research to Implementation: A Call for Global Action’. With this invitation to register, we are also calling for abstracts from all those involved in podoconiosis research and implementation. In order to stimulate high levels of participation, the conference programme will include two sessions of research presentations, one of implementation presentations, and a poster display area. Abstracts for each of these will be selected by competitive process, and prizes will be awarded for the best research and the best implementation presentations. Travel awards will be available for a limited number of selected abstracts.

Access Challenge Universal Health Forum
September 24, New York, New York
The Universal Health Forum will celebrate the drive towards Universal Health Access in Africa. There will be high-level forums on maternal health, child health and malaria, NTDs and NCDs. There will also be an exhibition hall showcasing new technology, diagnostics, and treatments, and a dinner and awards ceremony celebrating leaders from across Africa.

NNN 2018 
September 24-26, Addis Ababa, Ethiopia
We are delighted to announce the dates for the 9th NNN annual conference, subject to venue availability.

10th Euro-Global Conference on Infectious Diseases
September 27-29, Rome, Italy
Theme: Advancing in science and improving care to prevent infectious diseases.

International Conference on Migration Health
October 1-3, Rome, Italy
Hosted by the international Society of Travel Medicine.

5th Global Symposium on Health Systems Research
October 8-12,  Liverpool, United Kingdom
Theme: Advancing health systems for all in the SDG area.

World Sight Day
October 11, 2018
World Sight Day (WSD) is an annual day of awareness held on the second Thursday of October, to focus global attention on blindness and vision impairment. This year, the "Call to Action" for World Sight Day is "Eye Care Everywhere."

World Health Summit
October 14-16, Berlin, Germany
Central topics for this year's meeting will include pandemic preparedness, sustainable development goals, and access to essential medicines.

Neglected Tropical Diseases Congress: The Future Challenges
October 15-17, Abu Dhabi, United Arab Emirates
The conference includes prompt presentations, special sessions, workshops, symposium, oral talks, poster presentations and exhibitions. We expect your kind presence at the conference which will discuss the recent emerging diseases, outbreaks, categories, epidemiology, diagnosis, therapeutics etc.

Collaborations Addressing Vulnerable Populations Forum
October 16-17, Herndon, Virginia
The Collaborations Addressing Vulnerable Populations (CAVP) Forum is a platform dedicated to the steps being made across the biomedical landscape to provide healthcare solutions to populations that represent an unmet medical need. The CAVP Forum will provide attendees with the opportunity to attend sessions from five unique tracks. We will highlight how drug repurposing can alleviate development costs, discuss different ways to ensure access to safe and cost-affective drugs, examine regulatory pathways and incentives targeting rare and neglected tropical diseases, and explore public–private partnerships that support the development of new treatments for vulnerable populations.

The Roadmap to Echinococcosis Control in Peru: Review and Synthesis of the Evidence
October 16-18, Lima, Peru
The objectives of this workshop are to review the cystic echinococcosis situation in Latine American and Peru, to review state-of-the0art methodologies, and to evaluate the evidence generated by pilot projects. The workshop is being coordinated by the University of Surrey (UK) and the Universidad Nacional Mayor de San Marcos (Peru), and will have contributions from other leading researchers. We are now inviting Early Career Researchers (ECR) from the UK or Peru to apply to attend this workshop. All travel and accommodation expenses will be covered by the Research Links programme. Applications are welcome until 1 August. Successful candidates will be contacted in early August.

Tropical Dermatology
October 27 - 28, New Orleans, Louisiana
This 1.5-day course offers an overview of Tropical Dermatology, an essential component of tropical medicine. The course is designed for clinicians who are already familiar with clinical tropical medicine, either from working in tropical environments or from seeing patients returning from the tropics. Saturday’s session is devoted to cutaneous leishmaniais (the latest in the rapidly changing epidemiology, diagnosis and management). Skin conditions will be reviewed from the standpoint of diagnosing and treating individual patients – and from managing skin diseases on a population basis. 

Big Data and Genomics – A Practical Workshop on Sequence Analysis in Parasitology
October 28, New Orleans, Louisiana
This practical, hands-on workshop will introduce participants to publicly available sequence analysis tools. Using parasite genome and/or RNAseq data obtained from actual field or laboratory experiments, participants will learn analytical methods and workflows used to extract meaningful biological, evolutionary and/or epidemiological insights. Through live exercises led by experts in the field, participants will learn how to retrieve data from sequence repositories, run them through preconfigured or customized workflows, and visualize and explore the data using web-based tools.

The Global Health Impact of Urbanization and Megacities – Trends, Risk Management and Research Needs
October 28, New Orleans, Louisiana
This course will explore the changing worldwide landscape and global health risks with the exponential increase in urban population growth.  Beyond vector-borne diseases, the lack of barriers between animals, vectors, the environment and water supply increases the risk of other diseases such as leptospirosis, Ebola and plague. We urgently need to be prepared for new microbial transmission pathways in the urban environment that affect human health. 

67th Annual ASTMH Meeting 
October 28 - November 1, New Orleans, Louisiana
The ASTMH Annual Meeting draws tropical medicine and global health professionals representing academia, government, non-profits, philanthropy, NGOs, industry, military and private practice. The meeting is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students and all health care providers working in the fields of tropical medicine, hygiene and global health. 

7th Global Scabies Control Meeting
October 28, New Orleans, Louisiana
We are pleased to announce the date for the 7th Global Scabies Control meeting. The meeting will be held on Sunday 28th October in New Orleans, LA, USA. Please mark this in your diaries now! Further information and registration details will follow in coming months. 

1st International Caparica Congress on Leishmaniasis
October 29-31, Caparica, Portugal
This conference intends to gather researchers working in areas related to Leishmaniasis, from treatment to prevention. In fact, as leishmaniasis is slowly but constantly, increasing worldwide, this conference is addressed to show the latest research trends in this area. The idea is to push forward the battle against this persistent disease. 

Women Leaders in Global Health London 2018
November 8-9, London, United Kingdom
Celebrating women in global health leadership and cultivating the next generation of women leaders. 

APHA 2018 Annual Meeting and Expo
November 10-14, San Diego, California
Theme: "Creating the Healthiest Nation: Health Equity Now."  

Vector-Borne Diseases in the UK - Biennial Meeting, 2018
December 3-4, Norwich, United Kingdom
This meeting will be the fourth we have held on this topic, with previous meetings in 2012, 2014 and 2016, and like before we will bring together members of the major UK research groups who have an interest in vectors or vector-borne diseases which could be a threat to the UK; groups with wider but related areas of interest; members of key UK Government Departments and their Agencies; and representatives of European organisations with an interest in this topic. 

Women Deliver 2019 Conference 
June 3-6, 2019, Vancouver, Canada
The Women Deliver 2019 Conference – the world’s largest gathering on the health, rights, and wellbeing of women and girls – will serve as a fueling station for advocates working to achieve a more gender equal world. In the summer of 2019, over 6,000 world leaders, influencers, advocates, academics, activists, and journalists will flock to Vancouver with dreams of accelerating progress girls and women everywhere.